Toxicokinetics of 2-methylimidazole in male and female F344 rats. 2002

Jerry D Johnson, and Diana Reichelderfer, and Anup Zutshi, and Steven Graves, and Denise Walters, and Cynthia Smith
Battelle Memorial Institute, Columbus, Ohio 43201, USA. johnsojd@battelle.org

The toxicokinetics of 2-methylimidazole (2-MI) were studied in male and female Fischer 344 rats after a single iv dose of 10 mg/kg or gavage dose of 25, 50, or 100 mg/kg. The 2-MI was formulated in 0.05 M phosphate-buffered saline (pH 7.4). The iv profiles could be best described by a two-compartment model with first-order elimination. The terminal elimination half-life, volume of distribution at steady state, and clearance values were 0.78 and 0.85 h(-1), 1.5 and 1.9 L, and 4.97 and 12.0 L/h/kg for males and females, respectively. After a gavage dose, the plasma concentration time profiles could be best described by a one-compartment model, no lag phase, and first-order absorption and elimination. The peak 2-MI plasma concentrations increased proportionately with dose and were reached within 35 to 50 min (T(max)) for all groups. The estimated half-life value for 2-MI was about 1 h for the iv group and the male 25-, 50-, or 100-mg/kg groups and female 25-mg/kg groups. Clearance increased for the male 100- and female 50- and 100- mg/kg groups. For a given dose group, clearance was also two to three times greater for female rats when compared to male rats. Absolute bioavailability for 2-MI was estimated to approach 97%. The results of this study indicated that 2-MI was (1) rapidly and completely absorbed, (2) quickly eliminated, (3) cleared differently for females than for males, (4) affected somewhat by dose for females, and (5) unlikely to undergo tissue accumulation following repeated exposure.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004785 Environmental Pollutants Substances or energies, for example heat or light, which when introduced into the air, water, or land threaten life or health of individuals or ECOSYSTEMS. Environmental Pollutant,Pollutant,Pollutants,Pollutants, Environmental,Pollutant, Environmental
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Jerry D Johnson, and Diana Reichelderfer, and Anup Zutshi, and Steven Graves, and Denise Walters, and Cynthia Smith
August 1995, Xenobiotica; the fate of foreign compounds in biological systems,
Jerry D Johnson, and Diana Reichelderfer, and Anup Zutshi, and Steven Graves, and Denise Walters, and Cynthia Smith
August 2011, Toxicology letters,
Jerry D Johnson, and Diana Reichelderfer, and Anup Zutshi, and Steven Graves, and Denise Walters, and Cynthia Smith
December 1992, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Jerry D Johnson, and Diana Reichelderfer, and Anup Zutshi, and Steven Graves, and Denise Walters, and Cynthia Smith
July 2010, Environmental toxicology and pharmacology,
Jerry D Johnson, and Diana Reichelderfer, and Anup Zutshi, and Steven Graves, and Denise Walters, and Cynthia Smith
August 2000, Toxicological sciences : an official journal of the Society of Toxicology,
Jerry D Johnson, and Diana Reichelderfer, and Anup Zutshi, and Steven Graves, and Denise Walters, and Cynthia Smith
March 2000, Human & experimental toxicology,
Jerry D Johnson, and Diana Reichelderfer, and Anup Zutshi, and Steven Graves, and Denise Walters, and Cynthia Smith
January 2021, Journal of toxicologic pathology,
Jerry D Johnson, and Diana Reichelderfer, and Anup Zutshi, and Steven Graves, and Denise Walters, and Cynthia Smith
March 2013, Xenobiotica; the fate of foreign compounds in biological systems,
Jerry D Johnson, and Diana Reichelderfer, and Anup Zutshi, and Steven Graves, and Denise Walters, and Cynthia Smith
April 1993, Xenobiotica; the fate of foreign compounds in biological systems,
Jerry D Johnson, and Diana Reichelderfer, and Anup Zutshi, and Steven Graves, and Denise Walters, and Cynthia Smith
November 2013, Xenobiotica; the fate of foreign compounds in biological systems,
Copied contents to your clipboard!